Burka J F, Eyre P
Int Arch Allergy Appl Immunol. 1975;49(6):774-81. doi: 10.1159/000231461.
Slow-reacting substance of anaphylaxis (SRS-A) is released immunologically from bovine lung in vitro. Various drugs known to protect calves and other animals during anaphylaxis were tested to investigate their modulation of the formation and release of SRS-A. The anti-inflammatory drugs, meclofenamate and aspirin, potentiated SRS-A release. Chlorphenesin and diethylcarbamazine citrate at high concentrations both inhibited SRS-A release. Two new anti-anaphylactic drugs, PR-D-92-EA and M&B 22,948, were particularly effective in inhibiting SRS-A release at low concentrations. The possible modes of actions of these drugs are discussed.
过敏反应迟缓反应物质(SRS - A)可在体外通过免疫方式从牛肺中释放出来。对各种已知在过敏反应期间能保护小牛及其他动物的药物进行了测试,以研究它们对SRS - A形成和释放的调节作用。抗炎药甲氯芬那酸和阿司匹林增强了SRS - A的释放。高浓度的氯苯甘醚和枸橼酸乙胺嗪均抑制SRS - A的释放。两种新型抗过敏药PR - D - 92 - EA和M&B 22,948在低浓度时对抑制SRS - A的释放特别有效。讨论了这些药物可能的作用方式。